Home / Stocks / TRDA

TRDA insider trading

Entrada Therapeutics, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
4
Bought · 24 mo
$2.4M
Buys · last 90 days
0 · $0
Most recent buy
2026-05-21

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-05-21Zeiher Bernhardt G
Director
Bought5,000$5.86$29k
2025-11-24BAKER BROS. ADVISORS LP
10% owner
Bought28,867$9.07$262k
2025-11-18PARMAR KUSH
Director · 10% owner
Sold200,000$8.80$1.8M
2025-11-185AM Opportunities I (GP), LLC
10% owner
Sold200,000$8.80$1.8M
2025-11-12BAKER BROS. ADVISORS LP
10% owner
Bought178,044$7.60$1.4M
2025-06-18KIM PETER S
Director
Bought50,000$14.63$732k

Most active insider buyers

InsiderRoleBuysTotal bought
BAKER BROS. ADVISORS LP10% owner2$1.6M
KIM PETER SDirector1$732k
Zeiher Bernhardt GDirector1$29k

See TRDA on the chart

Every insider buy and sell for TRDA plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.